{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:41:43Z","timestamp":1787164903260,"version":"build-2736575974"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gram-negative bacterial infections are increasingly becoming resistant to available antibiotic treatment options. The World Health Organization attributed over 1 million deaths to bacterial antimicrobial resistance (AMR) in 2021. While there is a crisis in terms of the available effective antibiotic repertoire, there is also a simultaneous decline in novel drug discovery. In this scenario, the search for alternative or complementary therapeutic options is not only relevant, but also urgently needed. Bacterial virulence factors have been proposed as alternative therapeutic targets since there is lesser propensity for emergence of resistance to these effector molecules. Type 1 fimbriae or FimH of Enterobacteriaceae constitute such a potential target, as these structures are crucial for the initial adhesion and colonization by binding mannose-rich host cell-surface receptors. Additionally, FimH has been associated with multiple diseases, including urinary tract infections (UTIs) and Crohn\u2019s disease (CD). The elucidation of Escherichia coli FimH crystal structure has opened the possibility for structure-based drug design to combat these diseases. Many mannose-based compounds are being tried as alternative therapeutics against UTIs and CD with a few molecules showing promise. In this review, we discuss the role of FimH in different diseases, its potential and scope for structure-based development of different mannose-based compounds, and other advanced FimH-blocking therapeutics in preventing these infections.<\/jats:p>","DOI":"10.1093\/jambio\/lxag016","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:31:04Z","timestamp":1768307464000},"source":"Crossref","is-referenced-by-count":4,"title":["Type 1 fimbrial protein FimH of Enterobacteriaceae\u2014a promising target to mitigate different infections"],"prefix":"10.1093","volume":"137","author":[{"given":"Catherine E","family":"Thamayandhi","sequence":"first","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be-University) , Pillaiyarkuppam, Pondicherry 607 402 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-6715","authenticated-orcid":false,"given":"Atanu","family":"Manna","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be-University) , Pillaiyarkuppam, Pondicherry 607 402 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu K","family":"Singh","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be-University) , Pillaiyarkuppam, Pondicherry 607 402 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7929-8409","authenticated-orcid":false,"given":"Divya","family":"Lakshmanan","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be-University) , Pillaiyarkuppam, Pondicherry 607 402 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2026051410085012600_bib1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12937-022-00769-x","article-title":"Role of D-mannose in urinary tract infections\u2014a narrative review","volume":"21","author":"Ala-Jaakkola","year":"2022","journal-title":"Nutr J"},{"key":"2026051410085012600_bib2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/cc8850","article-title":"Role of CD14 in lung inflammation and infection","volume":"14","author":"Anas","year":"2010","journal-title":"Crit Care"},{"key":"2026051410085012600_bib3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1172\/jci30504","article-title":"CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease","volume":"117","author":"Barnich","year":"2007","journal-title":"J Clin Invest"},{"key":"2026051410085012600_bib4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/183782a0","article-title":"Non-flagellar appendages of bacteria","volume":"183","author":"Brinton","year":"1959","journal-title":"Nature"},{"key":"2026051410085012600_bib5","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1021\/jm400723n","article-title":"Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn\u2019s disease patients","volume":"56","author":"Brument","year":"2013","journal-title":"J Med Chem"},{"key":"2026051410085012600_bib6","doi-asserted-by":"publisher","first-page":"22439","DOI":"10.1073\/pnas.0902179106","article-title":"Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051410085012600_bib7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40168-021-01135-5","article-title":"Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn\u2019s disease","volume":"9","author":"Chevalier","year":"2021","journal-title":"Microbiome"},{"key":"2026051410085012600_bib8","doi-asserted-by":"publisher","first-page":"e00169","DOI":"10.1128\/iai.00169-24","article-title":"A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates","volume":"92","author":"Chorro","year":"2024","journal-title":"Infect Immun"},{"key":"2026051410085012600_bib74_375_222426","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13073-023-01243-x","article-title":"Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis","volume":"15","author":"Cu\u00e9nod","year":"2023","journal-title":"Genome Med"},{"key":"2026051410085012600_bib9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","article-title":"High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease","volume":"127","author":"Darfeuille-Michaud","year":"2004","journal-title":"Gastroenterology"},{"key":"2026051410085012600_bib10","doi-asserted-by":"publisher","first-page":"e03664","DOI":"10.1128\/mbio.03664-20","article-title":"Discovery of bacterial fimbria\u2013glycan interactions using whole-cell recombinant Escherichia coli expression","volume":"12","author":"Day","year":"2021","journal-title":"mBio"},{"key":"2026051410085012600_bib11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3934\/microbiol.2018.3.563","article-title":"Bacterial adherence: much more than a bond","volume":"4","author":"Di\u00a0Martino","year":"2018","journal-title":"AIMS Microbiol"},{"key":"2026051410085012600_bib12","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1111\/j.1365-2958.1992.tb02210.x","article-title":"A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence","volume":"6","author":"Donnenberg","year":"1992","journal-title":"Mol Microbiol"},{"key":"2026051410085012600_bib13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/path.1700920113","article-title":"Fimbriae and adhesive properties in salmonellae","volume":"92","author":"Duguid","year":"1966","journal-title":"J Pathol"},{"key":"2026051410085012600_bib14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1099\/00221287-21-1-271","article-title":"Fimbriae and adhesive properties in Klebsiella strains","volume":"21","author":"Duguid","year":"1959","journal-title":"J Gen Microbiol"},{"key":"2026051410085012600_bib15","doi-asserted-by":"publisher","first-page":"37707","DOI":"10.1074\/jbc.m501249200","article-title":"The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts","volume":"280","author":"Duncan","year":"2005","journal-title":"J Biol Chem"},{"key":"2026051410085012600_bib16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/cbic.201402714","article-title":"The tyrosine gate of the bacterial lectin FimH: a conformational analysis by NMR spectroscopy and X-ray crystallography","volume":"16","author":"Fiege","year":"2015","journal-title":"Chembiochem"},{"key":"2026051410085012600_bib17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/eji.200535149","article-title":"Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection","volume":"36","author":"Fischer","year":"2006","journal-title":"Eur J Immunol"},{"key":"2026051410085012600_bib18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.annemergmed.2018.05.006","article-title":"Emergency department urinary tract infections caused by extended-spectrum \u03b2-Lactamase\u2013producing enterobacteriaceae: many patients have no identifiable risk factor and discordant empiric therapy is common","volume":"72","author":"Frazee","year":"2018","journal-title":"Ann Emerg Med"},{"key":"2026051410085012600_bib19","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1128\/aac.00447-12","article-title":"Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice","volume":"56","author":"Guiton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026051410085012600_bib20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/s0022-2836(02)01005-7","article-title":"Exploring the 3D molecular architecture of Escherichia coli type 1 pili","volume":"323","author":"Hahn","year":"2002","journal-title":"J Mol Biol"},{"key":"2026051410085012600_bib73_804_221726","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1574-6976.2012.00339.x","article-title":"Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection","volume-title":"FEMS Microbiology Reviews","author":"Hannan","year":"2012"},{"key":"2026051410085012600_bib21","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/ejoc.201100407","article-title":"The bacterial lectin FimH, a target for drug discovery\u2014carbohydrate inhibitors of type 1 fimbriae-mediated bacterial adhesion","volume":"2011","author":"Hartmann","year":"2011","journal-title":"Eur J Org Chem"},{"key":"2026051410085012600_bib22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cbic.202000406","article-title":"Developments in mannose-based treatments for uropathogenic Escherichia coli\u2013induced urinary tract infections","volume":"22","author":"Hatton","year":"2021","journal-title":"ChemBioChem"},{"key":"2026051410085012600_bib23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"2026051410085012600_bib78_973_224726","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1046\/j.1365-2958.2002.02915.x","article-title":"Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection","volume":"44","author":"Hung","year":"2002","journal-title":"Molecular Microbiology"},{"key":"2026051410085012600_bib24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00203-024-04092-3","article-title":"Type 1 fimbria and P pili: regulatory mechanisms of the prototypical members of the chaperone-usher fimbrial family","volume":"206","author":"Isidro-Coxca","year":"2024","journal-title":"Arch Microbiol"},{"key":"2026051410085012600_bib25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1073\/pnas.92.6.2081","article-title":"FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae","volume":"92","author":"Jones","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051410085012600_bib26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s44149-023-00101-y","article-title":"Allelic functional variation of FimH among Salmonella enterica subspecies","volume":"3","author":"Kang","year":"2023","journal-title":"Animal Diseases"},{"key":"2026051410085012600_bib27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1462-5822.2006.00779.x","article-title":"FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells","volume":"9","author":"Khan","year":"2007","journal-title":"Cell Microbiol"},{"key":"2026051410085012600_bib28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/128_2008_13","article-title":"Structure, function, and assembly of type 1 fimbriae","volume":"288","author":"Knight","year":"2009","journal-title":"Top Curr Chem"},{"key":"2026051410085012600_bib29","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/molecules23071641","article-title":"Targeting dynamical binding processes in the design of non-antibiotic anti-adhesives by molecular simulation\u2014the example of FimH","volume":"23","author":"Krammer","year":"2018","journal-title":"Molecules"},{"key":"2026051410085012600_bib30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0882-4010(88)90073-3","article-title":"Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects","volume":"4","author":"Krogfelt","year":"1988","journal-title":"Microb Pathog"},{"key":"2026051410085012600_bib31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.276.5312.607","article-title":"Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination","volume":"276","author":"Langermann","year":"1997","journal-title":"Science"},{"key":"2026051410085012600_bib80_583_225926","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/jm040818l","article-title":"Multivariate design, synthesis, and biological evaluation of peptide inhibitors of FimC\/FimH protein-protein interactions in uropathogenic Escherichia coli","volume":"48","author":"Larsson","year":"2005","journal-title":"J Med Chem"},{"key":"2026051410085012600_bib32","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.bbrc.2005.06.180","article-title":"FimH adhesin of Escherichia coli K1 type 1 fimbriae activates BV-2 microglia","volume":"334","author":"Lee","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2026051410085012600_bib33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3762\/bjoc.6.90","article-title":"A bivalent glycopeptide to target two putative carbohydrate binding sites on FimH","volume":"6","author":"Lindhorst","year":"2010","journal-title":"Beilstein J Org Chem"},{"key":"2026051410085012600_bib34","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"2026051410085012600_bib35","doi-asserted-by":"publisher","first-page":"eadw0698","DOI":"10.1126\/sciadv.adw0698","article-title":"Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic E. coli UTI","volume":"11","author":"Lopatto","year":"2025","journal-title":"Sci Adv"},{"key":"2026051410085012600_bib36","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/mt.2010.75","article-title":"FimH can directly activate human and murine natural killer cells via TLR4","volume":"18","author":"Mian","year":"2010","journal-title":"Mol Ther"},{"key":"2026051410085012600_bib37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1574-6976.1996.tb00252.x","article-title":"Molecular and structural aspects of fimbriae biosynthesis and assembly in Escherichia coli","volume":"19","author":"Mol","year":"1996","journal-title":"FEMS Microbiol Rev"},{"key":"2026051410085012600_bib38","doi-asserted-by":"publisher","first-page":"e1012325","DOI":"10.1371\/journal.ppat.1012325","article-title":"Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine. Mulvey MA, ed","volume":"21","author":"Monerri\u00a0NCS\u00a0de","year":"2025","journal-title":"PLoS Pathog"},{"key":"2026051410085012600_bib39","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.4049\/jimmunol.181.10.6702","article-title":"Cutting edge: fimH adhesin of type 1 fimbriae is a novel TLR4 ligand","volume":"181","author":"Mossman","year":"2008","journal-title":"J Immunol"},{"key":"2026051410085012600_bib83_698_293526","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/pharmaceutics15020527","article-title":"Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists","volume":"15","author":"Mousavifar","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026051410085012600_bib79_124_225026","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.drudis.2021.02.025","article-title":"Recent development in the design of small \u2018drug-like\u2019 and nanoscale glycomimetics against Escherichia coli infections","volume-title":"Drug Discovery Today","author":"Mousavifar","year":"2021"},{"key":"2026051410085012600_bib40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1517\/13543776.2016.1131266","article-title":"Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohns disease","volume":"26","author":"Mydock-Mcgrane","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"2026051410085012600_bib41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/17460441.2017.1331216","article-title":"Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn\u2019s disease","volume":"12","author":"Mydock-McGrane","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"2026051410085012600_bib77_304_224326","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cytogfr.2023.08.008","article-title":"Multifaceted role of CD14 in innate immunity and tissue homeostasis","volume-title":"Cytokine Growth Factor Rev","author":"Na","year":"2023"},{"key":"2026051410085012600_bib82_388_290526","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cbic.202000406","article-title":"Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections","volume-title":"Chembiochem","author":"Natasha\u00a0E.","year":"2021"},{"key":"2026051410085012600_bib42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5489\/cuaj.8455","article-title":"MV140 sublingual vaccine reduces recurrent urinary tract infection in women results from the first North American clinical experience study","volume":"18","author":"Nickel","year":"2024","journal-title":"Can Urol Assoc J"},{"key":"2026051410085012600_bib43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jac\/dky405","article-title":"Empirical treatment of urinary tract infections: how rational are our guidelines?","volume":"74","author":"O\u2019Grady","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026051410085012600_bib81_742_221726","first-page":"71","article-title":"Serologic classification of fimbriae","volume":"151","author":"Orskov","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"2026051410085012600_bib45","doi-asserted-by":"publisher","first-page":"e00581","DOI":"10.1128\/iai.00581-17\/suppl_file\/zii999092195s1.pdf","article-title":"Role for FimH in extraintestinal pathogenic Escherichia coli invasion and translocation through the intestinal epithelium","volume":"85","author":"Poole","year":"2017","journal-title":"Infect Immun"},{"key":"2026051410085012600_bib46","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1016\/j.csbj.2022.08.040","article-title":"Conserved FimH mutations in the global Escherichia coli ST131 multi-drug resistant lineage weaken interdomain interactions and alter adhesin function","volume":"20","author":"Qin","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"2026051410085012600_bib47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1107\/s2052252516016675","article-title":"Mutation of Tyr137 of the universal Escherichia coli fimbrial adhesin FimH relaxes the tyrosine gate prior to mannose binding","volume":"4","author":"Rabbani","year":"2017","journal-title":"IUCrJ"},{"key":"2026051410085012600_bib48","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/acs.jafc.5b03030","article-title":"In vivo consumption of cranberry exerts ex vivo antiadhesive activity against FimH-dominated uropathogenic Escherichia coli: a combined in vivo, ex vivo, and in vitro study of an extract from Vaccinium macrocarpon","volume":"63","author":"Rafsanjany","year":"2015","journal-title":"J Agric Food Chem"},{"key":"2026051410085012600_bib49","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jgh.15828","article-title":"Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn\u2019s disease","volume":"37","author":"Reinisch","year":"2022","journal-title":"J of Gastro and Hepatol"},{"key":"2026051410085012600_bib50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1021\/ml400269v","article-title":"Validation of reactivity descriptors to assess the aromatic stacking within the tyrosine gate of FimH","volume":"4","author":"Roos","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"2026051410085012600_bib72_372_221326","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1371\/journal.pmed.0040329","article-title":"Detection of intracellular bacterial communities in human urinary tract infection","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"key":"2026051410085012600_bib51","doi-asserted-by":"publisher","first-page":"e00746","DOI":"10.1128\/iai.00746-17","article-title":"Context-dependent requirements for FimH and other canonical virulence factors in gut colonization by extraintestinal pathogenic Escherichia coli","volume":"86","author":"Russell","year":"2018","journal-title":"Infect Immun"},{"key":"2026051410085012600_bib69_513_224526","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/jb.174.18.5923-5935.1992","article-title":"Lesions in Two Escherichia coli Type 1 Pilus Genes Alter Pilus Number and Length without Affecting Receptor Binding","volume":"174","author":"Russell","year":"1992","journal-title":"J Bacteriol"},{"key":"2026051410085012600_bib52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9070397","article-title":"FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens","volume":"9","author":"Sarshar","year":"2020","journal-title":"Antibiotics"},{"key":"2026051410085012600_bib70_976_225326","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1086\/318855","article-title":"Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections","volume-title":"J Infect Dis","author":"Schilling","year":"2001"},{"key":"2026051410085012600_bib53","doi-asserted-by":"publisher","first-page":"15530","DOI":"10.1073\/pnas.1315203110","article-title":"Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation","volume":"110","author":"Schwartz","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051410085012600_bib54","doi-asserted-by":"publisher","first-page":"8922","DOI":"10.1073\/pnas.95.15.8922","article-title":"Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin","volume":"95","author":"Sokurenko","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051410085012600_bib55","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1039\/B610745A","article-title":"Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: design, synthesis and binding properties of mannoside ligands","volume":"4","author":"Sperling","year":"2006","journal-title":"Org Biomol Chem"},{"key":"2026051410085012600_bib56","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1128\/iai.73.5.2923-2931.2005","article-title":"Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state","volume":"73","author":"Teng","year":"2005","journal-title":"Infect Immun"},{"key":"2026051410085012600_bib57","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.2.4.2.1","article-title":"Fimbriae: classification and biochemistry","volume":"2","author":"Thanassi","year":"2007","journal-title":"EcoSal Plus"},{"key":"2026051410085012600_bib58","doi-asserted-by":"publisher","first-page":"113093","DOI":"10.1016\/j.ejmech.2020.113093","article-title":"Does targeting Arg98 of FimH lead to high affinity antagonists?","volume":"211","author":"Toma\u0161i\u010d","year":"2021","journal-title":"Eur J Med Chem"},{"key":"2026051410085012600_bib59","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/infdis\/jit245","article-title":"A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131","volume":"208","author":"Totsika","year":"2013","journal-title":"J Infect Dis"},{"key":"2026051410085012600_bib60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jmii.2020.09.001","article-title":"Escherichia coli FimH adhesins act synergistically with PapGII adhesins for enhancing establishment and maintenance of kidney infection","volume":"55","author":"Tseng","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"2026051410085012600_bib61","doi-asserted-by":"publisher","first-page":"e00881","DOI":"10.1128\/iai.00881-18","article-title":"Salmonella fimbrial protein FimH is involved in expression of proinflammatory cytokines in a toll-like receptor 4-dependent manner","volume":"87","author":"Uchiya","year":"2019","journal-title":"Infect Immun"},{"key":"2026051410085012600_bib62","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/antibiotics11030314","article-title":"Why d-Mannose may be as efficient as antibiotics in the treatment of acute uncomplicated lower urinary tract infections-preliminary considerations and conclusions from a non-interventional study","volume":"11","author":"Wagenlehner","year":"2022","journal-title":"Antibiotics"},{"key":"2026051410085012600_bib63","doi-asserted-by":"publisher","first-page":"e2040","DOI":"10.1371\/journal.pone.0002040","article-title":"Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex","volume":"3","author":"Wellens","year":"2008","journal-title":"PLoS One"},{"key":"2026051410085012600_bib64","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1021\/bi300251r","article-title":"The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH","volume":"51","author":"Wellens","year":"2012","journal-title":"Biochemistry"},{"key":"2026051410085012600_bib65","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41467-025-63276-7","article-title":"Fishing out AIEC with FimH capturing microgels for inflammatory bowel disease treatment","volume":"16","author":"Wu","year":"2025","journal-title":"Nat Commun"},{"key":"2026051410085012600_bib75_629_223026","doi-asserted-by":"publisher","first-page":"2193115","DOI":"10.1080\/19490976.2023.2193115","article-title":"Crohn's disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"key":"2026051410085012600_bib66","doi-asserted-by":"publisher","first-page":"1284770","DOI":"10.3389\/fimmu.2023.1284770","article-title":"Escherichia coli adhesion protein FimH exacerbates colitis via CD11b+CD103\u2212 dendritic cell activation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"2026051410085012600_bib67","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41467-020-15030-4","article-title":"Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"2026051410085012600_bib76_981_223426","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.12998\/wjcc.v10.i32.11671","article-title":"Role of adherent invasive Escherichia coli in pathogenesis of inflammatory bowel disease","volume":"10","author":"Zheng","year":"2022","journal-title":"World J Clin Cases"},{"key":"2026051410085012600_bib68","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3389\/fimmu.2017.01552","article-title":"CRISPRi induced suppression of Fimbriae gene (fimH) of a uropathogenic Escherichia coli: an approach to inhibit microbial biofilms","volume":"8","author":"Zuberi","year":"2017","journal-title":"Front Immunol"}],"container-title":["Journal of Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jambio\/advance-article-pdf\/doi\/10.1093\/jambio\/lxag016\/66410936\/lxag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/137\/2\/lxag016\/66410936\/lxag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/137\/2\/lxag016\/66410936\/lxag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:08:59Z","timestamp":1778767739000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jambio\/article\/doi\/10.1093\/jambio\/lxag016\/8425339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jambio\/lxag016","relation":{},"ISSN":["1365-2672"],"issn-type":[{"value":"1365-2672","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,14]]},"article-number":"lxag016"}}